<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus MPharm Non Grading System 0th Semester Pharmacology</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: underline; font-size: 11.5pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 13.5pt; }
 h2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11.5pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 7.5pt; vertical-align: 4pt; }
 .h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: underline; font-size: 13.5pt; }
 .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; margin:0pt; }
 .s4 { color: black; font-family:"Cambria Math", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11.5pt; }
 h3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: underline; font-size: 9.5pt; }
 .s5 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9.5pt; }
 a { color: #00F; font-family:Calibri, sans-serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 10.5pt; }
 .s6 { color: #00F; font-family:Calibri, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10.5pt; }
 .s7 { color: black; font-family:Calibri, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 1; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 1; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 1; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)". "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 li {display: block; }
 #l4 {padding-left: 0pt;counter-reset: e1 1; }
 #l4> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)". "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l4> li:first-child>*:first-child:before {counter-increment: e1 0;  }
</style><!-- Basic Meta Tags -->
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="viewport" content="width=device-width,initial-scale=1" />

<!-- Page Title and Description -->
<meta name="description" content="Download and view the latest RGPV syllabus and timetable in PDF." />
<meta name="keywords" content="download, view, RGPV, syllabus, timetable, PDF" />

<!-- Robots Meta Tag -->
<meta name="robots" content="index, follow" />
<link rel="sitemap" href="/sitemap.xml" />

<!-- Twitter Meta Tags -->
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:title" content="RGPV Syllabus and Timetable" />
<meta name="twitter:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Open Graph Meta Tags -->
<meta property="og:locale" content="en_IN" />
<meta property="og:type" content="website" />
<meta property="og:site_name" content="RGPV Syllabus and Timetable" />
<meta property="og:title" content="RGPV Syllabus and Timetable" />
<meta property="og:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Other Tags -->
<link rel="prefetch" />
<meta name="audience" content="all" />
<meta name="rating" content="general" />
<meta name="generator" content="site" />
<meta name="google" content="translate" />
<meta name="theme-color" content="#4DBA87" />
<meta name="geo.placename" content="India" />
<meta name="revisit-after" content="1 days" />
<meta property="fb:admins" content="100012765211323" />
<meta name="apple-mobile-web-app-capable" content="no" />

<!-- Apple Touch Icon -->
<meta name="apple-mobile-web-app-title" content="www.rgpv-syllabus-timetable.in" />
<meta name="apple-mobile-web-app-status-bar-style" content="default" />
<link rel="apple-touch-icon" href="/img/icons/apple-touch-icon-152x152.png" />

<!-- Favicon and Icons -->
<link rel="mask-icon" href="/img/icons/safari-pinned-tab.svg" color="#4DBA87" />
<link rel="icon" type="image/png" sizes="32x32" href="/img/icons/favicon-32x32.png" />
<link rel="icon" type="image/png" sizes="16x16" href="/img/icons/favicon-16x16.png" />
<meta name="msapplication-TileImage" content="/img/icons/msapplication-icon-144x144.png" />

<!-- Search Engine Tags -->
<meta name="search engines" content="Aeiwi, Alexa, AllTheWeb, AltaVista, AOL Netfind, Anzwers, Canada, DirectHit, EuroSeek, Excite, Overture, Go, Google, HotBot, InfoMak, Kanoodle, Lycos, MasterSite, National Directory, Northern Light, SearchIt, SimpleSearch, WebsMostLinked, WebTop, What-U-Seek, AOL, Yahoo, WebCrawler, Infoseek, Excite, Magellan, LookSmart, CNET, Googlebot" />

<!-- Pingback and OpenID -->
<link rel="pingback" href="https://www.rgpv-syllabus-timetable.in/" />
<link rel="openid.delegate" href="https://www.rgpv-syllabus-timetable.in/" />

<!-- Content Type -->
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<body><div style="display:flex;justify-content:flex-end;"><a rel="nofollow" href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download PDF</button></a></div><script>const a=(window.location.pathname).split("/");const filename="" + a[a.length-1] + ".pdf";document.getElementById("pdf-download-link").href=filename;</script><p class="s1" style="padding-top: 5pt;padding-left: 9pt;text-indent: 0pt;text-align: center;">RAJIV GANDHI PROUDYOGIKI VISHWAVIDYALAYA</p><p class="s2" style="padding-left: 9pt;text-indent: 0pt;text-align: center;">M.Pharm. (Pharmacology)</p><h2 style="padding-left: 142pt;text-indent: 0pt;text-align: center;">3<span class="s3">rd</span> Semester Elective Course Contents Elective-I</h2><p class="s1" style="padding-left: 9pt;text-indent: 0pt;line-height: 15pt;text-align: center;">MPY 301 PCL : <span class="h1">CLINICAL RESEARCH</span></p><h2 style="padding-left: 8pt;text-indent: 0pt;text-align: center;">Unit I</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">New drug discovery process and clinical evaluation of new drugs. Terminologies, Defining the Research Team; roles, responsibilities, organization structure. Clinical trial Site inititation, subject recruitment, exclusion/inclusion criteria, end-points in clinical trial. Informed Consent formates and regulations. Patient counseling and interviewing techniques, Improving patient compliance and patient monitoring. Pharmaco-epidemiology.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit II</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Clinical research Methodologies: Experimental design: Experimental design in clinical trials, Control in clinical trials, Randomization, Blinding, Statistical Analysis, Experimental planning and monitoring, Recognising sources of bias and minimising its effect, non-parametric and parametric analysis. Case record forms, Statistical quality control.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit III</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Clinical trial protocol writing and documentations. Sampling techniques, Sampling Design, types of sampling, Probability and non probability sampling, Methods of drawing samples, Sample size determination, Sampling error.</p><p style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Phases of clinical research.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit IV</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Performing and interpretation of Clinical Trials: Data collection, Data analysis, meta analysis and reporting. Measuring treatment effects, Racial, gender and ethnic differences in drugs response. Data validation, query management, Softwares in clinical data management. Tables &amp; Graphs, Measures of Central Tendency, Measures of variation, hypothesis testing. Report writing and presentation.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit V</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Regulatory requirements, essential documents and regulatory submission, supervision of ethics, compliance and audits, Institutional Review Board (Role and responsibility, members and auditing), The Declaration of Helsinki, The Belmont Report, GCP &amp; ICH guidelines, Schedule</p><p style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Y. Country specific trial filing requirement.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Recommended books:</p><ol id="l1"><li data-list-text="1."><p style="padding-left: 23pt;text-indent: -18pt;text-align: left;">Elementary Statistical Quality Control, Volume 25, Burr, I. W., New York: Marcel Dekker, Inc.</p></li><li data-list-text="2."><p style="padding-left: 23pt;text-indent: -18pt;line-height: 13pt;text-align: left;">Managing the clinical drug development process, C. Nardi, Marcel Dekker, New York, USA.</p></li><li data-list-text="3."><p style="padding-left: 23pt;text-indent: -18pt;text-align: left;">Pharmaceutical Statistics by Sanford Bolton, Marcel Dekker, New York, USA, Informa Healthcare; 4 edition.</p></li><li data-list-text="4."><p style="padding-left: 23pt;text-indent: -18pt;line-height: 13pt;text-align: left;">Clinical Trials by L Duley and B Farrell, BMJ Books, London.</p></li><li data-list-text="5."><p style="padding-left: 23pt;text-indent: -18pt;text-align: left;">Handbook for good clinical research practice WHO Library Catalogue.</p></li><li data-list-text="6."><p style="padding-left: 23pt;text-indent: -18pt;text-align: left;">Artciles: ICH-GCP, Schedule Y, US FDA guidelines, WHO Guidelines.</p></li><li data-list-text="7."><p style="padding-top: 5pt;padding-left: 23pt;text-indent: -18pt;text-align: left;">Design of experiments. A realistic approach by V L Anderson and Robert Mclean, Marcel Dekker, New York, USA.</p></li><li data-list-text="8."><p style="padding-left: 23pt;text-indent: -18pt;text-align: left;">Fundamentals of Clinical Research: Bridging Medicine, Statistics and Operations, Antonella Bacchieri and Giovanni Della Cioppa, Springer.</p></li><li data-list-text="9."><p style="padding-left: 23pt;text-indent: -18pt;text-align: left;">The CRC&#39;s Guide to Coordinating Clinical Research, Second Ed, by Karen E. Woodin, CentreWatch Publication.</p></li><li data-list-text="10."><p style="padding-left: 23pt;text-indent: -18pt;line-height: 13pt;text-align: left;">A Guide to Patient Recruitment and Retention by Anderson D. L., CentreWatch Publication.</p></li><li data-list-text="11."><p style="padding-left: 23pt;text-indent: -18pt;text-align: left;">The CRA&#39;s Guide to Monitoring Clinical Research, Third Edition by Woodin K. E., CentreWatch Publication.</p></li><li data-list-text="12."><p style="padding-left: 23pt;text-indent: -18pt;text-align: left;">The CRC&#39;s Guide to Coordinating Clinical Research, Second Edition by Woodin K E., CentreWatch Publication.</p></li><li data-list-text="13."><p style="padding-left: 23pt;text-indent: -18pt;text-align: left;">Clinical Research Environment in India by Umakanta Sahoo, Faiz Kermani, ICFAI University Press.</p><p class="s1" style="padding-top: 5pt;padding-left: 9pt;text-indent: 0pt;text-align: center;">RAJIV GANDHI PROUDYOGIKI VISHWAVIDYALAYA</p><p class="s2" style="padding-left: 9pt;text-indent: 0pt;text-align: center;">M.Pharm. (Pharmacology)</p><h2 style="padding-left: 142pt;text-indent: 0pt;text-align: center;">3<span class="s3">rd</span> Semester Elective Course Contents Elective-II</h2><p class="s1" style="padding-left: 9pt;text-indent: 0pt;line-height: 15pt;text-align: center;">MPY 302 PCL : <span class="h1">BIOLOGICAL EVALUATION OF DRUGS</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT<span class="s4">‐</span>I</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Anatomical  and  physiological  considerations  of  commonly  used  laboratory  animals. Maintenance and breeding of Laboratory animals. Design, management and safety of laboratory for biological evaluation of drugs.</p><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Anatomical specifications, advantage &amp; limitations of various anatomical sites of blood collection in laboratory animals. Specifications of laboratory anesthetic agents, their use in specific condition.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT<span class="s4">‐</span>II</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Bioassays: Principle, types and methods of bioassays, advantages  over other assays. Official bioassays. Bioassay of official drugs. Biological standardization of vaccines and sera.</p><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Methods of bioassay of adrenaline, nor-adrenaline, acetylcholine,  histamine,  angiotensin, d- tubocurarine, insulin, digoxin, oxytocin, estrogen, thyroxine, corticotrophin and somatotrophin.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT<span class="s4">‐</span>III</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Bioassay design and techniques: Experimental models and statistical experimental designs employed  in  biological  standardization. Statistical  quality control.  Introduction  to  high- throughput screening and modern techniques like ligand-binding studies and use of tissue culture in biological evaluation of drugs. Development of new bioassay.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT<span class="s4">‐</span>IV</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Toxicity tests, Methods of acute, subacute, and chronic toxicity studies. Elementary knowledge of systemic toxicology, Toxicology of central nervous system, peripheral nervous system, liver, kidney,  respiratory  system,  haematopoietic  system,  reproductive  system  etc.  Regulatory standards and requirements for toxicity data of various regulatory bodies.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT<span class="s4">‐</span>V</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Clinical trials: Clinical trial designs, Approved procedures, Protocols and regulatory guidelines, i.e., Helsinki declaration, USFDA &amp; ICH guidelines for Clinical trials of drugs, Reviews &amp; approval of Clinical Study, Good Clinical Practices.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Recommended books:</h3><ol id="l2"><li data-list-text="1."><p class="s5" style="padding-left: 31pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Drug Discovery and Evaluation by Vogel HG. Springer, N Y</p></li><li data-list-text="2."><p class="s5" style="padding-left: 31pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Practical Pharmacology by Burn, J.H. Blackwell Scientific Co. Oxford</p></li><li data-list-text="3."><p class="s5" style="padding-left: 31pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Screening Methods in pharmacology. Vols I and II by A. Turner, Academic Press.</p></li><li data-list-text="4."><p class="s5" style="padding-left: 31pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Evaluation of Drug Activities: Pharmacometrics by Lawrence and Bacharach, Academic Press.</p></li><li data-list-text="5."><p class="s5" style="padding-left: 31pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Drug Bioscreening by Thompson, E.B. VCH, New York</p></li><li data-list-text="6."><p class="s5" style="padding-left: 31pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Various regulatory guideliens like ICH, GCP, Helsinki, USFDA etc.</p></li><li data-list-text="7."><p class="s5" style="padding-left: 31pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Pharmacopoeia: IP, BP, USP etc.</p></li><li data-list-text="8."><p class="s5" style="padding-left: 31pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Transgenic Animal Technology, Second Edition: A Laboratory Handbook by Carl A. Pinkert, Academic press</p></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-top: 4pt;padding-left: 9pt;text-indent: 0pt;text-align: center;">RAJIV GANDHI PROUDYOGIKI VISHWAVIDYALAYA</p><p class="s2" style="padding-left: 9pt;text-indent: 0pt;text-align: center;">M.Pharm. (Pharmacology)</p><h2 style="padding-left: 142pt;text-indent: 0pt;text-align: center;">3<span class="s3">rd</span> Semester Elective Course Contents Elective-III</h2><p class="s1" style="padding-left: 9pt;text-indent: 0pt;line-height: 15pt;text-align: center;">MPY 303 PCL : <span class="h1">PHARMACOVIGILANCE</span></p><h2 style="padding-left: 9pt;text-indent: 0pt;text-align: center;">Unit-I</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Introduction, Principles of pharmacovigilance, Frequency and importance of adverse drug reaction, Pharmacovigilance methods, Setting up and operating a Pharmacovigilance centre, terminologies, Resources for pharmacovigilance centres, Role of pharmacist, Computer system in recording and interpretation of adverse drug reaction (ADR) information, Interpretation and use of information from spontaneous ADR reporting systems.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit-II</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Pharmacoepidemiology: Basic epidemiological principles, cohort studies, Case control studies, Prescription event monitoring, Drug utilization studies, Information sources and system available for pharmacoepidemiological studies, Benefit/harm ratio.</p><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Pharmacogenetics: Genetic polymorphism in xenobiotic metabolizing enzymes, Mechanisms of allelic  variation  in  xenobiotic  metabolizing  enzymes,  Pharmacologic  consequences  and contribution in ADR of a genetic polymorphism.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit-III</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: left;">Standard operating procedures in Pharmacovigilance, case evaluation- casuality assessment, Managing individual case report forms, Signal analysis, follow-up and Root cause analysis of medication errors. Medical Information System, Risk –benefit assessment and management in Pharmacovigilance, Communicating pharmacovigilance information. Disease specific tool kit. pharmacovigilance of Vaccines, Herbal and other complementary medicines.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit-IV</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Post-marketing drug safety: Differences in clinical and post-marketing drug safety, Reporting to the Regulatory Authorities: Individual case safety reports, Periodic safety update reports, Answering queries from regulatory authorities, Updating product labeling – emphasis on safety changes, Safety reporting requirements, Safety report sources, Follow up of safety reports, Electronic safety reporting systems and software program available, Safety file retention.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit-V</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Global Pharmacovigilance System and safety standards, WHO programme for international drug monitoring,  Global  regulatory  requirements  and  guidelines,  Compliance  monitoring  and Pharmacovigilance  inspections,  National  Pharmacovigilance  Programme,  Objectives, Programme  governance,  Reporting  structures,  Communication  and  Framework  in  india. Authority and Industry perspectives, ICH, FDA guidelines.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Recommended books:</p><ol id="l3"><li data-list-text="1."><p style="padding-left: 27pt;text-indent: -17pt;text-align: left;">Pharmacovigilance (2nd Ed) by Ronald D.Mann &amp; Elizabeth B. Andrews, John Wiley &amp; Sons</p></li><li data-list-text="2."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Pharmacovigilance from A to Z - Barton L. Cobert &amp; Pierre Biron, Blackwell Science</p></li><li data-list-text="3."><p style="padding-top: 5pt;padding-left: 27pt;text-indent: -17pt;text-align: left;">Manual of Drug Safety and Pharmacovigilance by Barton L. Cobert, Jones &amp; Bartlett</p></li><li data-list-text="4."><p style="padding-left: 27pt;text-indent: -17pt;text-align: left;">An Introduction to Pharmacovigilance by Waller, Patrick; John Wiley &amp; Sons</p></li><li data-list-text="5."><p style="padding-left: 27pt;text-indent: -17pt;text-align: left;">“Good Pharmacovigilance Practice” MHRA guidelines</p></li><li data-list-text="6."><p style="padding-left: 27pt;text-indent: -17pt;text-align: left;">Various national and international guidelines.</p></li><li data-list-text="7."><p style="padding-left: 27pt;text-indent: -17pt;text-align: left;">Strengthening Pharmaceutical Systems (SPS). Supporting Pharmacovigilance in Developing Countries: The Systems Perspective. Submitted to the U.S. agency for international Development by the SPS Program. Arlington, Va: management Sciences for health. September 2009</p></li><li data-list-text="8."><p class="s6" style="padding-left: 27pt;text-indent: -17pt;text-align: left;"><span style=" color: #00F; font-family:Calibri, sans-serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 10.5pt;">http://apps.who.int/medicinedocs/en/d/Jh2992e/</span> <span class="p">Safety of Medicines - A Guide to Detecting and Reporting Adverse Drug Reactions - Why Health Professionals Need to Take Action</span></p></li><li data-list-text="9."><p class="s6" style="padding-left: 27pt;text-indent: -17pt;text-align: left;"><span style=" color: #00F; font-family:Calibri, sans-serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 10.5pt;">http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdf</span> <span class="p">The safety of medicines in public health programmes: pharmacovigilance an essential tool by World Health Organization 2006</span></p></li><li data-list-text="10."><p class="s6" style="padding-left: 27pt;text-indent: -17pt;text-align: left;"><span style=" color: #00F; font-family:Calibri, sans-serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 10.5pt;">http://www.who.int/medicines/technical_briefing/tbs/handbook_antimalarialpharmvigilance.pdf</span> <span class="p">A practical handbook on the pharmacovigilance of antimalarial medicines by © World Health Organization 2007</span></p></li><li data-list-text="11."><p style="padding-left: 48pt;text-indent: -24pt;text-align: left;">	World Health Organization WHO Technical Report Series, No. 850, 1995, Annex 3 Guidelines for good clinical practice (GCP) for trials on pharmaceutical products</p></li></ol><p style="padding-left: 41pt;text-indent: 0pt;text-align: left;"><a href="http://www.pvtoolkit.org/index.php?option=com_content&amp;view=article&amp;id=6&amp;Itemid=10">http://www.pvtoolkit.org/index.php?option=com_content&amp;view=article&amp;id=6&amp;Itemid=10</a></p><p class="s1" style="padding-top: 5pt;padding-left: 9pt;text-indent: 0pt;text-align: center;">RAJIV GANDHI PROUDYOGIKI VISHWAVIDYALAYA</p><p class="s2" style="padding-left: 9pt;text-indent: 0pt;text-align: center;">M.Pharm. (Pharmacology)</p><h2 style="padding-left: 142pt;text-indent: 0pt;text-align: center;">3<span class="s3">rd</span> Semester Elective Course Contents Elective-IV</h2><p class="s1" style="padding-left: 9pt;text-indent: 0pt;line-height: 15pt;text-align: center;">MPY 304 PCL : <span class="h1">PHARMACOLOGICAL DRUG SCREENING</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit I</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Principles, techniques and strategies used in new drug discovery. Methodologies in Evaluation of potential new drug, Types of drug screening models, Correlations between various animal models and human clinical data, Regulatory guidelines in extrapolation of human dose. Application of molecular biology in screeing models. Software assisted screening of drug molecule.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit II</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Correlation between in-vitro and in-vivo screens, Alternatives to animal screening procedures, patch-clamp technique, Molecular biology techniques, Cell line based assay, Biochemical assay, Radioligand binding assay, Recent development of advanced and automated screening models.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit III</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Design  of  Experiments:  Objectives,  Strategies,  Experimental  design,  Basic  principles- replication, Randomization, Blocking, Meaning and purpose of research design, Types of research design, Criteria of a good research design.</p><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Guidelines for design of experiments: Simple Comparative Experiments, Basic statistical concepts, Random variable, Sample mean and variance, Degrees of freedom, Standard and normal distribution, Statistical hypothesis, t-test, P-value, Confidence Intervals, Paired and unpaired comparisons</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit IV</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: justify;">Pharmacological  screening  models  of  new  drugs  belonging  to  following  categories: Antileishmaniasis,   antifilariasis,   anthelmintics,   Antifertility   agents,   antiobesity, antiatherosclerotic, eicosanoids, antidiabetics and drug affecting various ion channels like calcium, sodium, potassium,</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit V</h2><p style="padding-left: 10pt;text-indent: 0pt;text-align: left;">Principle, development methodologies, maintenance and examples of various Transgenic animals and other genetically prone animal models used in screening of various drug categories. Principles of toxicity evaluations, ED50, LD50 and TD values.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 10pt;text-indent: 0pt;text-align: left;">Recommended books:</p><ol id="l4"><li data-list-text="1."><p style="padding-left: 23pt;text-indent: -13pt;line-height: 14pt;text-align: left;">Drug Discovery and Evaluation by H. Gerhard Vogel, Springer, <span class="s7">N Y.</span></p></li><li data-list-text="2."><p style="padding-left: 23pt;text-indent: -13pt;line-height: 13pt;text-align: left;">Screening Methods in pharmacology. Vols I and II by A. Turner, Academic Press.</p></li><li data-list-text="3."><p style="padding-left: 23pt;text-indent: -13pt;text-align: left;">Applied Biopharmaceutics and Pharmacokinetics by Leon Shargel, McGraw Hill</p></li><li data-list-text="4."><p style="padding-left: 23pt;text-indent: -13pt;text-align: left;">Clinical Pharmacokinetics: Concepts and application by Rowland and Tozer, Lippincott</p></li><li data-list-text="5."><p style="padding-left: 23pt;text-indent: -13pt;text-align: left;">Handbook of Experimental Pharmacology by Hofmann, F.B., Springer</p></li><li data-list-text="6."><p style="padding-left: 23pt;text-indent: -13pt;text-align: left;">Fundamentals of Experimental Pharmacology by Gohsh, M.N., Scientific Book Agency, Calcutta.</p></li><li data-list-text="7."><p style="padding-top: 5pt;padding-left: 23pt;text-indent: -13pt;text-align: left;">Pharmacological Experiments on Isolated Preparations,by Perry, E&amp;S Livingstone, London.</p></li><li data-list-text="8."><p style="padding-left: 23pt;text-indent: -13pt;text-align: left;">Transgenic Animal Technology, Second Edition: A Laboratory Handbook by Carl A. Pinkert, Academic press</p></li></ol></body></html>
